Biosyngen debuts TIL 2.0, tumors tremble

Biosyngen debuts TIL 2.0, tumors tremble

At Asia Bio, the biotech’s slide deck promised 90 % response rates—oncologists now queue to decode the cell-cultivation cheat sheet.